TYRO3 agonist as therapy for glomerular disease
Fang Zhong(Icahn School of Medicine at Mount Sinai), John Cijiang He(James J. Peters VA Medical Center), Hong Cai(Institute of Soil Science), David R. Bauman(Icahn School of Medicine at Mount Sinai), Bhaskar C. Das(Long Island University), Jia Fu(Harbin Medical University), Zhengzhe Li(Gannan Medical University), Zeguo Sun(Icahn School of Medicine at Mount Sinai), Kyung Lee(Icahn School of Medicine at Mount Sinai), Lois Wang(Icahn School of Medicine at Mount Sinai)
Cited by 11
Related Papers
Glomerular endothelial cell injury and cross talk in diabetic kidney disease
|American Journal of Physiology-Renal Physiology|2014|274
Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2019|215
A reference tissue atlas for the human kidney
|Science Advances|2022|170
Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways
|Journal of Clinical Investigation|2004|156
LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β–Induced Angiogenesis
|Journal of the American Society of Nephrology|2019|149